Victor Chen, MD
Rheumatology · Canton, GANPI 1417950668
Payments from drug & device makers
Across 655 payments — averaging $105.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$41K
- GSK$17K
- UCB, Inc.$3K
- AbbVie$2K
- Amgen$2K
- Johnson & Johnson$950
- plus $4K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 82 | $40,976 |
| GSK | 20 | $16,569 |
| UCB, Inc. | 117 | $3,111 |
| AbbVie | 131 | $2,021 |
| Amgen(2 entities) | 77 | $1,670 |
| Johnson & Johnson(2 entities) | 52 | $950 |
| Novartis | 51 | $917 |
| AstraZeneca(2 entities) | 21 | $722 |
| Lilly USA, LLC | 19 | $459 |
| E.r. Squibb & Sons, L.L.C. | 20 | $388 |
| ANI Pharmaceuticals, Inc. | 9 | $254 |
| Mallinckrodt Hospital Products Inc. | 8 | $243 |
| Boehringer Ingelheim | 9 | $215 |
| Sobi, Inc | 9 | $153 |
| Radius Health, Inc. | 1 | $122 |
| Organon | 4 | $96 |
| Nevro Corp. | 1 | $68 |
| Pacira Therapeutics, Inc. | 3 | $56 |
| Portola Pharmaceuticals, LLC | 1 | $48 |
| Bristol Myers Squibb | 2 | $42 |
| Biotronik NRO, Inc. | 2 | $42 |
| Medexus Pharma, Inc. | 3 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Mallinckrodt Enterprises LLC | 1 | $29 |
| Gilead | 2 | $26 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $23 |
| Biocon Biologics Inc | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| Janssen Scientific Affairs, LLC | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $13 |
| Smith+Nephew | 1 | $12 |
How this compares
$69,394 in reported general payments places this provider in the 85th percentile of 177 rheumatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Canton
- Theresa Lawrence FordLawrenceville$2.9M
- Wambui MachuaAtlanta$1.8M
- Brent FlickingerGainesville$1.6M
- James MossellTifton$1.6M
- Roel QuerubinMarietta$1.5M
- Arezou KhosroshahiAtlanta$1.5M
- Sung LimAtlanta$1.3M
- Gary MyersonAtlanta$1.3M
- Jefrey LiebermanDecatur$761K
- Marta BognarGainesville$719K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.